• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于计算机的决策辅助工具对乳腺癌易感性基因检测的知识、认知及意愿的影响:一项随机对照试验。

Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.

作者信息

Green Michael J, Peterson Susan K, Baker Maria Wagner, Harper Gregory R, Friedman Lois C, Rubinstein Wendy S, Mauger David T

机构信息

Department of Humanities, Penn State College of Medicine, Hershey, Pa 17033, USA.

出版信息

JAMA. 2004 Jul 28;292(4):442-52. doi: 10.1001/jama.292.4.442.

DOI:10.1001/jama.292.4.442
PMID:15280342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1237120/
Abstract

CONTEXT

As the availability of and demand for genetic testing for hereditary cancers increases in primary care and other clinical settings, alternative or adjunct educational methods to traditional genetic counseling will be needed.

OBJECTIVE

To compare the effectiveness of a computer-based decision aid with standard genetic counseling for educating women about BRCA1 and BRCA2 genetic testing.

DESIGN

Randomized controlled trial conducted from May 2000 to September 2002.

SETTING AND PARTICIPANTS

Outpatient clinics offering cancer genetic counseling at 6 US medical centers enrolled 211 women with personal or family histories of breast cancer.

INTERVENTIONS

Standard one-on-one genetic counseling (n = 105) or education by a computer program followed by genetic counseling (n = 106).

MAIN OUTCOME MEASURES

Participants' knowledge, risk perception, intention to undergo genetic testing, decisional conflict, satisfaction with decision, anxiety, and satisfaction with the intervention. Counselor group measures were administered at baseline and after counseling. Computer group measures were administered at baseline, after computer use, and after counseling. Testing decisions were assessed at 1 and 6 months. Outcomes were analyzed by high vs low risk of carrying a BRCA1 or BRCA2 mutation.

RESULTS

Both groups had comparable demographics, prior computer experience, medical literacy, and baseline knowledge of breast cancer and genetic testing, and both counseling and computer use were rated highly. Knowledge scores increased in both groups (P<.001) regardless of risk status, and change in knowledge was greater in the computer group compared with the counselor group (P =.03) among women at low risk of carrying a mutation. Perception of absolute risk of breast cancer decreased significantly after either intervention among all participants. Intention to undergo testing decreased significantly after either intervention among low-risk but not high-risk women. The counselor group had lower mean scores on a decisional conflict scale (P =.04) and, in low-risk women, higher mean scores on a satisfaction-with-decision scale (P =.001). Mean state anxiety scores were reduced by counseling but were within normal ranges for both groups at baseline and after either intervention, regardless of risk status.

CONCLUSIONS

An interactive computer program was more effective than standard genetic counseling for increasing knowledge of breast cancer and genetic testing among women at low risk of carrying a BRCA1 or BRCA2 mutation. However, genetic counseling was more effective than the computer at reducing women's anxiety and facilitating more accurate risk perceptions. These results suggest that this computer program has the potential to stand alone as an educational intervention for low-risk women but should be used as a supplement to genetic counseling for those at high risk.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/1237120/bca5d8dff979/nihms2783f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/1237120/bca5d8dff979/nihms2783f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/1237120/bca5d8dff979/nihms2783f1.jpg
摘要

背景

随着初级保健及其他临床环境中遗传性癌症基因检测的可及性和需求增加,将需要传统遗传咨询之外的替代或辅助教育方法。

目的

比较基于计算机的决策辅助工具与标准遗传咨询在对女性进行BRCA1和BRCA2基因检测教育方面的效果。

设计

2000年5月至2002年9月进行的随机对照试验。

地点和参与者

美国6家医疗中心提供癌症遗传咨询的门诊诊所招募了211名有乳腺癌个人或家族史的女性。

干预措施

标准一对一遗传咨询(n = 105)或通过计算机程序进行教育后再进行遗传咨询(n = 106)。

主要结局指标

参与者的知识、风险认知、进行基因检测的意愿、决策冲突、对决策的满意度、焦虑程度以及对干预措施的满意度。咨询师组的指标在基线时和咨询后进行测量。计算机组的指标在基线时、使用计算机后以及咨询后进行测量。在1个月和6个月时评估检测决策。根据携带BRCA1或BRCA2突变的高风险与低风险对结局进行分析。

结果

两组在人口统计学特征、既往计算机使用经验、医学素养以及乳腺癌和基因检测的基线知识方面具有可比性,并且对咨询和计算机使用的评价都很高。无论风险状态如何,两组的知识得分均有所提高(P<.001),在携带突变低风险的女性中,计算机组的知识变化大于咨询师组(P =.03)。所有参与者在任何一种干预后,对乳腺癌绝对风险的认知均显著降低。在低风险而非高风险女性中,任何一种干预后进行检测的意愿均显著降低。咨询师组在决策冲突量表上的平均得分较低(P =.04),在低风险女性中,在决策满意度量表上的平均得分较高(P =.001)。咨询降低了平均状态焦虑得分,但无论风险状态如何,两组在基线时和任何一种干预后的平均状态焦虑得分均在正常范围内。

结论

对于携带BRCA1或BRCA2突变低风险的女性,交互式计算机程序在增加乳腺癌和基因检测知识方面比标准遗传咨询更有效。然而,在减轻女性焦虑和促进更准确的风险认知方面,遗传咨询比计算机更有效。这些结果表明,该计算机程序有可能单独作为低风险女性的教育干预措施,但对于高风险女性应作为遗传咨询的补充。

相似文献

1
Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.基于计算机的决策辅助工具对乳腺癌易感性基因检测的知识、认知及意愿的影响:一项随机对照试验。
JAMA. 2004 Jul 28;292(4):442-52. doi: 10.1001/jama.292.4.442.
2
Facilitating decision-making in women undergoing genetic testing for hereditary breast cancer: BRECONDA randomized controlled trial results.促进遗传性乳腺癌基因检测女性的决策制定:BRECONDA 随机对照试验结果。
Breast. 2017 Dec;36:79-85. doi: 10.1016/j.breast.2017.10.001. Epub 2017 Oct 12.
3
Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.关于采用预测试教育方法以增强BRCA1基因检测知情决策的对照试验。
J Natl Cancer Inst. 1997 Jan 15;89(2):148-57. doi: 10.1093/jnci/89.2.148.
4
Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions.在进行乳腺癌易感性遗传咨询前使用教育性计算机程序:对咨询 session 的时长和内容的影响 。(注:这里“session”结合语境可理解为咨询环节、咨询时段等,但直接保留英文更准确传达原文意思,因为中文里没有完全对应的简洁词汇)
Genet Med. 2005 Apr;7(4):221-9. doi: 10.1097/01.gim.0000159905.13125.86.
5
Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.BRCA1/BRCA2 突变携带者决策辅助工具的随机试验:对决策制定和满意度指标的影响
Health Psychol. 2009 Jan;28(1):11-19. doi: 10.1037/a0013147.
6
An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility.一个交互式计算机程序可以有效地对患者进行关于乳腺癌易感性基因检测的教育。
Am J Med Genet. 2001 Sep 15;103(1):16-23. doi: 10.1002/ajmg.1500.
7
Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.针对携带BRCA1或BRCA2基因突变女性的乳腺癌预防决策辅助工具的开发与测试。
Clin Genet. 2007 Sep;72(3):208-17. doi: 10.1111/j.1399-0004.2007.00859.x.
8
Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.患者和临床医生决策支持以增加初级保健中遗传性乳腺癌和卵巢癌综合征的遗传咨询:一项集群随机临床试验。
JAMA Netw Open. 2022 Jul 1;5(7):e2222092. doi: 10.1001/jamanetworkopen.2022.22092.
9
Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.研究方案:一项关于基于网络的决策支持工具在初级保健中增加BRCA1/2基因咨询转诊的整群随机对照试验。
BMC Health Serv Res. 2018 Aug 13;18(1):633. doi: 10.1186/s12913-018-3442-x.
10
Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.有乳腺癌家族史的健康女性:定制的遗传咨询干预对风险认知、知识及绝经治疗决策的影响
J Womens Health (Larchmt). 2006 Sep;15(7):843-56. doi: 10.1089/jwh.2006.15.843.

引用本文的文献

1
A WeChat-Based Decision Aid Intervention to Promote Informed Decision-Making for Family Members Regarding the Genetic Testing of Patients With Colorectal Cancer: Randomized Controlled Trial.一项基于微信的决策辅助干预措施,以促进结直肠癌患者家属在基因检测方面做出明智决策:随机对照试验
J Med Internet Res. 2025 Apr 21;27:e60681. doi: 10.2196/60681.
2
Genetics Adviser: The development and usability testing of a new patient digital health application to support clinical genomic testing.遗传学顾问:一款支持临床基因组检测的新型患者数字健康应用程序的开发与可用性测试。
Genet Med Open. 2024 Jan 23;2:101814. doi: 10.1016/j.gimo.2024.101814. eCollection 2024.
3

本文引用的文献

1
Commentary: Computers and Genetic Counseling-Time for a Dialogue?评论:计算机与遗传咨询——是时候进行对话了?
J Genet Couns. 2000 Aug;9(4):359-61. doi: 10.1023/A:1009462314724.
2
Psychosocial issues in cancer genetics--current status and future directions.癌症遗传学中的社会心理问题——现状与未来方向
Acta Oncol. 2003;42(4):276-86. doi: 10.1080/02841860310004391.
3
Primary care physicians' attitudes and practices regarding cancer genetics: a comparison of 2001 with 1996 survey results.基层医疗医生对癌症遗传学的态度和做法:2001年与1996年调查结果的比较。
Genetics Navigator: protocol for a mixed methods randomized controlled trial evaluating a digital platform to deliver genomic services in Canadian pediatric and adult populations.
遗传导航员:一项混合方法随机对照试验的方案,旨在评估一个数字平台在加拿大儿科和成人人群中提供基因组服务的效果。
BMJ Open. 2024 Sep 3;14(9):e090084. doi: 10.1136/bmjopen-2024-090084.
4
Decision aids for people facing health treatment or screening decisions.决策辅助工具用于帮助面临医疗保健治疗或筛查决策的人。
Cochrane Database Syst Rev. 2024 Jan 29;1(1):CD001431. doi: 10.1002/14651858.CD001431.pub6.
5
Risk-management decision-making data from a community-based sample of racially diverse women at high risk of breast cancer: rationale, methods, and sample characteristics of the Daughter Sister Mother Project survey.基于社区的、种族多样的乳腺癌高风险女性样本的风险管理决策数据:女儿姐妹母亲项目调查的基本原理、方法和样本特征。
Breast Cancer Res. 2024 Jan 11;26(1):8. doi: 10.1186/s13058-023-01753-x.
6
Impact of a risk based breast screening decision aid on understanding, acceptance and decision making.基于风险的乳腺癌筛查决策辅助工具对理解、接受度和决策制定的影响。
NPJ Breast Cancer. 2023 Aug 8;9(1):65. doi: 10.1038/s41523-023-00569-4.
7
A practical method for integrating community priorities in planning and implementing cancer control programs.一种将社区优先事项纳入癌症控制规划和实施的实用方法。
Cancer Causes Control. 2023 Dec;34(Suppl 1):113-123. doi: 10.1007/s10552-023-01688-w. Epub 2023 Apr 18.
8
Finding the sweet spot: a qualitative study exploring patients' acceptability of chatbots in genetic service delivery.找到最佳平衡点:一项探索患者对遗传服务中使用聊天机器人可接受性的定性研究。
Hum Genet. 2023 Mar;142(3):321-330. doi: 10.1007/s00439-022-02512-2. Epub 2023 Jan 11.
9
Digital health-enabled genomics: Opportunities and challenges.数字健康赋能的基因组学:机遇与挑战。
Am J Hum Genet. 2022 Jul 7;109(7):1190-1198. doi: 10.1016/j.ajhg.2022.05.001.
10
Acceptability of an mHealth breast cancer risk-reduction intervention promoting risk assessment, education, and discussion of risk in the primary care setting.在初级保健环境中促进风险评估、教育及风险讨论的移动健康乳腺癌风险降低干预措施的可接受性。
Mhealth. 2021 Oct 20;7:54. doi: 10.21037/mhealth-20-82. eCollection 2021.
J Cancer Educ. 2003 Summer;18(2):91-4. doi: 10.1207/S15430154JCE1802_11.
4
US physicians' attitudes toward genetic testing for cancer susceptibility.美国医生对癌症易感性基因检测的态度。
Am J Med Genet A. 2003 Jul 1;120A(1):63-71. doi: 10.1002/ajmg.a.10192.
5
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
6
Genetic testing: psychological aspects and implications.基因检测:心理层面及影响
J Consult Clin Psychol. 2002 Jun;70(3):784-97. doi: 10.1037//0022-006x.70.3.784.
7
Interest in BRCA1/2 testing in a primary care population.对初级保健人群进行BRCA1/2检测的关注。
Prev Med. 2002 Jun;34(6):590-5. doi: 10.1006/pmed.2002.1022.
8
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.风险顾问和计算机模型BRCAPRO对BRCA1或BRCA2突变的检测前预测。
J Natl Cancer Inst. 2002 Jun 5;94(11):844-51. doi: 10.1093/jnci/94.11.844.
9
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.BRCAPRO验证、BRCA1/BRCA2基因检测的敏感性以及其他乳腺癌易感基因的患病率。
J Clin Oncol. 2002 Jun 1;20(11):2701-12. doi: 10.1200/JCO.2002.05.121.
10
Health decision aids to facilitate shared decision making in office practice.用于促进门诊实践中共同决策的健康决策辅助工具。
Ann Intern Med. 2002 Jan 15;136(2):127-35. doi: 10.7326/0003-4819-136-2-200201150-00010.